Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Metabolic Associated Steatotic Liver Disease · Nonalcoholic Steatohepatitis · Hepatic Steatosis
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 120 Estimated
- Expected completion
- Feb 17, 2028
- Record updated
- Mar 19, 2026
- Lead sponsor
- Hudson Biotech